Eugia receives FDA approval for Lidocaine HCl Injection Multiple-Dose Vials!
Published: October 31, 2017
On October 30, 2017 Eugia received FDA approval for Lidocaine HCl Injection Multiple-Dose Vials. Eugia currently markets the Single-Dose Vials and looks forward to the growth of this product family.
This product has an estimated annual market size of $39.5 million through June 2017 according to IMS data.